INFUSION PUMPS MARKET ANALYSIS

The global infusion pump market was valued at US$ 8.87 Bn in 2022 and is forecast to reach a value of US$ 16.91 Bn by 2030 at a CAGR of 8.4% between 2023 and 2030. The global infusion pump market is experiencing strong growth due to the growing burden of chronic disease and growing geriatric population worldwide. Moreover, increase in demand for infusion pump and increase in adoption of smart infusion pumps is expected to augment the market growth. However, factors such as the safety issues and stringent rules and regulations and high cost of infusion pumps are expected to hamper the infusion pump market growth.

Global Infusion Pump Market: Regional Insights

Based on geography, the global infusion pump market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing prevalence of chronic disease, such as cancer and diabetes, growing geriatric population, increasing demand for infusion pumps, and rise in adoption of smart/portable infusion pumps in the region. For instance, in August 2022, Baxter International Inc. received the U.S. Food and Drug Administration (FDA) 510(k) clearance of its new Novum IQ syringe infusion pump (SYR). Novum IQ SYR utilizes intuitive technologies built to help reduce infusion errors and designed to meet rigorous FDA guidance for infusion devices.

Europe and Asia Pacific are also expected to witness robust growth in the global infusion pump market owing to the rise in burden of chronic disease, growing geriatric population, and increase in adoption of smart/portable infusion pumps in these regions. For instance, with the rise in burden of chronic disease, such as cancer and diabetes, the use or demand for novel infusion pumps is also increasing with the rapid pace. In September 2022, Insulet announced that the Omnipod 5 system received CE mark clearance, making it available throughout the European Union. It’s cleared for use by adults and children aged two and older with type-1 diabetes.

Figure 1. Global Infusion Pump Market Share (%), by Region, 2023

To learn more about this report, request sample copy

Global Infusion Pump Market Drivers:

Growing burden of chronic disease to propel market growth

One of the key factors expected to augment the growth of the global infusion pump market during the forecast period is the growing burden of chronic disease, such as cancer and diabetes, around the globe. Infusion pump is a medical device that delivers fluids into a patient's body in controlled amounts. A pump replaces the need for multiple daily injections with a continuous insulin infusion, and helps improve blood sugar levels. According to the International Diabetes Federation (IDF), around 537 million adults (20 to 79 years) are living with diabetes, and the number of people living with diabetes is expected to reach 643 million by 2030 and 783 million by 2045.

Growing geriatric population to drive market growth

Another factor which is driving growth of the global infusion pump market is the growing geriatric (aging) population around the world. For instance, the geriatric population is more susceptible to chronic disease, and the high risk of chronic and long-term health conditions increases the demand for infusion pumps/therapies. According to the World Health Organization (WHO), 1 in 6 people in the world will be aged 60 years and more by 2030, and the world’s population of people aged 60 years and older will double (2.1 billion) by 2050. Thus, with the growing geriatric population, the demand for infusion pumps is also increasing rapidly.

Global Infusion Pump Market Opportunities:

Increase in demand for infusion pump across the globe is expected to provide significant growth opportunities for player in the global infusion pump market. For instance, infusion pumps are used to deliver nutrients or medications, in small or large amounts, such as insulin or other hormones, pain relievers, antibiotics, and chemotherapy drugs, among others. In November 2022, Medtronic plc announced the U.S. launch of Medtronic Extended infusion set, the first and only infusion set labelled for up to 7-day wear. An infusion set is tubing that delivers insulin from an insulin pump to the body and typically requires a set change every two to three days.

Technological advancements or increase in adoption of smart infusion pumps is expected to offer lucrative growth opportunities for players in the global infusion pump market. For instance, players in the market are focusing on developing and launching smart, technologically advanced infusion pumps in the market. In December 2022, Baxter received 510(k) clearance of its new Novum IQ syringe infusion pump. A pump can fully integrate with hospital electronic medical records (EMR) through Baxter’s IQ Enterprise Connectivity Suite. Novum IQ SYR offer enhanced safety features and is designed to help deliver optimum accuracy.

Global Infusion Pump Market Trends:

Growing number of surgical procedures is a recent trend

Elastomeric pumps, also known as balloon pumps, are used to administer liquid drugs such as local anesthetics, analgesics, cytostatics, or antibiotics (depending on a therapy). They are designed for continuous drug delivery, on-demand delivery, or combination of both continuous and on-demand drug delivery. Thus, with the increasing number of surgical procedures, the use and/or demand for infusion pumps is also increasing with the rapid pace. This trend is expected to continue over the forecast period, driving the growth of the infusion pump market.

High demand for volumetric infusion pumps is another trend

Volumetric infusion pumps have a wide range of applications in disease management as well as in parenteral nutrition compared to other pumps. The high demand for volumetric pumps is attributed to the safety, accuracy and simplicity of these pumps. Moreover, the adoption of technologically advanced volumetric pumps with capabilities, such as electronic health record (EHR) integration, built-in security systems, and others is expected to augment the market growth. This trend is also expected to continue over the forecast period.

Global Infusion Pump Market Restraints:

Safety issues and stringent regulations to hinder market growth

One of the key factors expected to hamper growth of the global infusion pump market is the safety issues and stringent rules and regulations. Infusion pumps pose risks to patient safety due to their complexity and multiple steps required in their administration. Studies have found that IV infusion is associated with around 56% of medication errors, 54% of all adverse drug events, and 61% of serious and life-threatening errors. Therefore, the quality of medical device and their approvals are governed by the regulatory authorities of respective countries; to protect the risks associated with the design, manufacture, and packaging of the device.

High cost of infusion pumps to hamper the market growth

Another factor which is hampering the growth of the global infusion pump market is the high cost of infusion pumps. For instance, infusion pumps are in widespread use in clinical settings such as hospitals, nursing homes, and in the home. However, cost of infusion pump is directly associated to the types, specification, and features of the infusion pump, and it also depends of the brand or a company. The cost of infusion pump in India is around INR. 20000 to INR. 1.5 lakh (the infusion pump price range includes all types of pump, such as syringe pump, feeding pump, and volumetric infusion pump, among others. This in turn is restraining the market growth.

Figure 2. Global Infusion Pump Market Share (%), by Product, 2023

To learn more about this report, request sample copy

Global Infusion Pump Market Segmentation:

The global infusion pump market report is segmented into Product, Technology, Usage, Application, End User, and Geography.

Based on Product, the market is segmented into Large Volume Infusion Pumps, Syringe Infusion Pumps, Insulin Pumps, Enteral Feeding Pumps, Elastomeric Pumps, and Implantable Pumps. Out of which, Large Volume Infusion Pumps Segment is expected to dominate the infusion pump market over the forecast period and this is attributed to the rise in burden of chronic disease. They are used to deliver continuous and very specific amounts of fluids at very slow to very fast rates.

Insulin Pumps Segment is also expected to witness significant growth in the near future and this is owing to the increasing prevalence of diabetes worldwide.

Based on Technology, the market is segmented into Traditional and Specialty. Out of which, Specialty Segment is expected to dominate the market over the forecast period and is attributed to the increasing prevalence and incidence of non-communicable diseases. The specialty segment includes the implantable infusion pump, enteral feeding pump, and insulin infusion pump.

Based on Usage, the market is segmented into Stationary and Ambulatory. Of which, Stationary Segment is expected to dominate the market over the forecast period and this is attributed to the increase in demand for infusion pumps worldwide. 

Ambulatory Segment is also expected to witness significant growth in the near future and this is owing to rise in adoption of smart infusion pumps worldwide.

Based on Application, the market is segmented into Oncology, Diabetes, Gastroenterology, Pediatrics and Neonatology, Pain Management, and Others. Out of which, Oncology Segment is expected to dominate the market over the forecast period and this is attributed to the increasing prevalence of cancer across the globe.

Diabetes Segment is also expected to witness significant growth in the near future and this is owing to rise in burden of diabetes and rise in adoption of insulin pumps.

Based on End User, the market is segmented into Hospitals, Home Healthcare Settings, Nursing Homes and Others. Out of which, Hospitals Segment is expected to dominate the market over the forecast period and this is attributed to the rise in burden of chronic disease.

Home Healthcare Settings Segment is also expected to witness robust growth in the near future and this is owing to rise in adoption and awareness among people.

Global Infusion Pump Market: Key Developments

In February 2023, Mindray announced the launch of BeneFusion i Series and u Series infusion systems featuring high precision, adaptive customization, and simplicity for guaranteed levels of medication safety in a variety of clinical settings.

In March 2022, Shanghai MicroPort Lifesciences Co., Ltd. received the marketing approval from China’s National Medical Products Administration (NMPA) for its independently-developed new AutoEx Chemotherapy Infusion Pump (AutoEx).

In November 2020, Baxter received Health Canada marketing authorization for its new Novum IQ Infusion Platform. The marketing authorization in Canada includes Novum IQ large volume (LVP) and syringe infusion pumps, representing Baxter’s latest developments.

In June 2019, the U.S. Food and Drug Administration (FDA) issued 510(k) clearance for the Ivenix Infusion System, ushering in a new era of infusion systems designed to make infusions safer, while lowering the total cost of ownership. The Ivenix Infusion System meet the new FDA guidelines to address the recurring safety problems associated with infusion pumps.

Global Infusion Pump Market: Key Companies Insights

The global infusion pump market is highly competitive. This is attributed to the rise in burden of chronic disease and growing geriatric population, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global infusion pump market are BD, Fresenius Kabi, ICU Medical, Smiths Medical, Medtronic, and B. Braun Melsungen, among others.

*Definition: An infusion pump is a medical device used to deliver fluids, such as nutrients and medications, into a patient's body in controlled amounts. Infusion pumps are in widespread use in clinical settings such as hospitals, nursing homes, and in the home.